16:@0.021502:0.039294:0.047607:0.039294:0.047607:0.019261:0.021502:0.019261:0.000000:0.000000
Drug-class overview:@0.097208:0.039084:0.342812:0.039084:0.342812:0.019649:0.097208:0.019649:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.097141:0.974259:0.701335:0.974259:0.701335:0.960936:0.097141:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.701335:0.974259:0.705081:0.974259:0.705081:0.960936:0.701335:0.960936:0.000000
VOLUME 1:@0.705252:0.974259:0.786566:0.974259:0.786566:0.959690:0.705252:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
neurological deficits caused by cerebral :@0.096970:0.096562:0.479951:0.096562:0.479951:0.081574:0.096970:0.081574:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
vasospasm following subarachnoid haemorrhage :@0.096970:0.111802:0.479990:0.111802:0.479990:0.096814:0.096970:0.096814:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of aneurismal origin:@0.096970:0.127042:0.249581:0.127042:0.249581:0.112054:0.096970:0.112054:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage::@0.096970:0.146741:0.166396:0.146741:0.166396:0.130350:0.096970:0.130350:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.166395:0.140964:0.172622:0.140964:0.172622:0.131408:0.166395:0.131408:0.000000
Iv infusion: For the first two hours infuse 1 mg :@0.096970:0.161550:0.479932:0.161550:0.479932:0.146561:0.096970:0.146561:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
each hour, increase to 2 mg/hour after two hours, :@0.096970:0.176353:0.480028:0.176353:0.480028:0.161365:0.096970:0.161365:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
provided no increase in bP is observed   Patients :@0.096970:0.191157:0.479970:0.191157:0.479970:0.176168:0.096970:0.176168:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.401461:0.190641:0.410274:0.190641:0.410274:0.175956:0.401461:0.175956:0.000000
with body mass less than 70 kg or unstable bP :@0.096970:0.205960:0.479951:0.205960:0.479951:0.190971:0.096970:0.190971:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
start at a dose of 0.5 mg or less if necessary   oral: :@0.096970:0.220763:0.480067:0.220763:0.480067:0.205775:0.096970:0.205775:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.428208:0.220248:0.437021:0.220248:0.437021:0.205563:0.428208:0.205563:0.000000
Follow Iv administration 60 mg every 4 hours for :@0.096970:0.235567:0.479970:0.235567:0.479970:0.220578:0.096970:0.220578:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
21 days    total dose: 360 mg/d   Prophylactic :@0.096970:0.250370:0.479970:0.250370:0.479970:0.235382:0.096970:0.235382:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.166800:0.249854:0.175613:0.249854:0.175613:0.235170:0.166800:0.235170:0.000000
:@0.364458:0.249854:0.373271:0.249854:0.373271:0.235170:0.364458:0.235170:0.000000
administration: Start therapy no later than 4 days :@0.096970:0.265174:0.479970:0.265174:0.479970:0.250185:0.096970:0.250185:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
after haemorrhage and continue during period of :@0.096970:0.279977:0.479951:0.279977:0.479951:0.264989:0.096970:0.264989:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
maximum vasospasm. If haemorrhage source is :@0.096970:0.294781:0.479990:0.294781:0.479990:0.279792:0.096970:0.279792:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
treated surgically, continue Iv treatment for 5 days :@0.096970:0.309584:0.480009:0.309584:0.480009:0.294595:0.096970:0.294595:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
post-operation, then continue with oral treatment :@0.096970:0.324388:0.479932:0.324388:0.479932:0.309399:0.096970:0.309399:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
for a further 7 days   therapeutic administration: :@0.096970:0.339191:0.479990:0.339191:0.479990:0.324202:0.096970:0.324202:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.250485:0.338675:0.259298:0.338675:0.259298:0.323991:0.250485:0.323991:0.000000
If ischaemic neurological disturbances caused :@0.096989:0.353994:0.479990:0.353994:0.479990:0.339006:0.096989:0.339006:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
by vasospasm after aneurismal subarachnoid :@0.096989:0.368798:0.480009:0.368798:0.480009:0.353809:0.096989:0.353809:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
haemorrhage are  present,  treat  as early as :@0.096989:0.383601:0.479990:0.383601:0.479990:0.368613:0.096989:0.368613:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
possible and continue for at least 5 days up :@0.096989:0.398405:0.479970:0.398405:0.479970:0.383416:0.096989:0.383416:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
to a maximum of 14 days. Continue with oral :@0.096989:0.413208:0.480009:0.413208:0.480009:0.398220:0.096989:0.398220:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
treatment to complete 21-day treatment period. :@0.096989:0.428012:0.480028:0.428012:0.480028:0.413023:0.096989:0.413023:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
If  haemorrhage  source  is  treated  surgically, :@0.096989:0.442815:0.479951:0.442815:0.479951:0.427826:0.096989:0.427826:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
continue Iv therapy 5 days post-operatively:@0.096989:0.457618:0.428959:0.457618:0.428959:0.442630:0.096989:0.442630:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.096989:0.476880:0.254776:0.476880:0.254776:0.460489:0.096989:0.460489:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.254755:0.471045:0.260981:0.471045:0.260981:0.461489:0.254755:0.461489:0.000000
Pregnancy   lactation   Concomitant rifampicin, :@0.096970:0.491630:0.479951:0.491630:0.479951:0.476641:0.096970:0.476641:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.183599:0.491114:0.192412:0.491114:0.192412:0.476430:0.183599:0.476430:0.000000
:@0.274731:0.491114:0.283544:0.491114:0.283544:0.476430:0.274731:0.476430:0.000000
phenytoin, phenobarbital and carbamazepine:@0.096970:0.506433:0.449375:0.506433:0.449375:0.491445:0.096970:0.491445:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effect::@0.096970:0.525695:0.191835:0.525695:0.191835:0.509304:0.096970:0.509304:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.191833:0.519908:0.198060:0.519908:0.198060:0.510352:0.191833:0.510352:0.000000
thrombocytopenia    allergic reactions    rash :@0.096970:0.540493:0.479970:0.540493:0.479970:0.525505:0.096970:0.525505:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.254930:0.539977:0.263743:0.539977:0.263743:0.525293:0.254930:0.525293:0.000000
:@0.420781:0.539977:0.429594:0.539977:0.429594:0.525293:0.420781:0.525293:0.000000
:@0.096970:0.554781:0.105783:0.554781:0.105783:0.540096:0.096970:0.540096:0.000000
 Headache   Hyperkinesia    tachycardia  or :@0.105783:0.555297:0.480009:0.555297:0.480009:0.540308:0.105783:0.540308:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.207190:0.554781:0.216003:0.554781:0.216003:0.540096:0.207190:0.540096:0.000000
:@0.338577:0.554781:0.347390:0.554781:0.347390:0.540096:0.338577:0.540096:0.000000
bradycardia :@0.097008:0.570100:0.191065:0.570100:0.191065:0.555112:0.097008:0.555112:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.203149:0.569584:0.211962:0.569584:0.211962:0.554900:0.203149:0.554900:0.000000
  Hypotension :@0.211962:0.570100:0.331400:0.570100:0.331400:0.555112:0.211962:0.555112:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.343484:0.569584:0.352297:0.569584:0.352297:0.554900:0.343484:0.554900:0.000000
  vasodilatation :@0.352297:0.570100:0.480047:0.570100:0.480047:0.555112:0.352297:0.555112:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475833:0.570100:0.480047:0.570100:0.480047:0.555112:0.475833:0.555112:0.000000
:@0.097047:0.584388:0.105860:0.584388:0.105860:0.569703:0.097047:0.569703:0.000000
 GI disturbances   local reactions with injection :@0.105860:0.584904:0.480047:0.584904:0.480047:0.569915:0.105860:0.569915:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.235534:0.584388:0.244347:0.584388:0.244347:0.569703:0.235534:0.569703:0.000000
administration:@0.097066:0.599707:0.208441:0.599707:0.208441:0.584718:0.097066:0.584718:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precautions::@0.097066:0.618969:0.269497:0.618969:0.269497:0.602578:0.097066:0.602578:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.269398:0.613174:0.275624:0.613174:0.275624:0.603618:0.269398:0.603618:0.000000
Impaired  liver  function :@0.096970:0.633759:0.307674:0.633759:0.307674:0.618771:0.096970:0.618771:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.324088:0.633243:0.332901:0.633243:0.332901:0.618559:0.324088:0.618559:0.000000
  discontinue  if :@0.332901:0.633759:0.479990:0.633759:0.479990:0.618771:0.332901:0.618771:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hypotension occurs   do not administer tablets :@0.096989:0.648563:0.480028:0.648563:0.480028:0.633574:0.096989:0.633574:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.257605:0.648047:0.266418:0.648047:0.266418:0.633362:0.257605:0.633362:0.000000
and Iv infusion concomitantly :@0.097008:0.663366:0.371135:0.663366:0.371135:0.648377:0.097008:0.648377:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.384913:0.662850:0.393726:0.662850:0.393726:0.648166:0.384913:0.648166:0.000000
 Cerebral :@0.393707:0.663366:0.480009:0.663366:0.480009:0.648377:0.393707:0.648377:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
oedema    Severe  raised  IC  pressure    Systolic :@0.097008:0.678170:0.480009:0.678170:0.480009:0.663181:0.097008:0.663181:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.169956:0.677654:0.178769:0.677654:0.178769:0.662969:0.169956:0.662969:0.000000
:@0.400576:0.677654:0.409389:0.677654:0.409389:0.662969:0.400576:0.662969:0.000000
bP <100 mmHg   Monitor renal function during :@0.097008:0.692973:0.480028:0.692973:0.480028:0.677984:0.097008:0.677984:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.227856:0.692457:0.236669:0.692457:0.236669:0.677773:0.227856:0.677773:0.000000
treatment with Iv solution in renal disease or :@0.097008:0.707776:0.480028:0.707776:0.480028:0.692788:0.097008:0.692788:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
nephrotoxic drug use   Iv solution contains :@0.097008:0.722580:0.479990:0.722580:0.479990:0.707591:0.097008:0.707591:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.289586:0.722064:0.298399:0.722064:0.298399:0.707380:0.289586:0.707380:0.000000
alcohol   Grapefruit juice should be avoided :@0.097008:0.737383:0.480047:0.737383:0.480047:0.722395:0.097008:0.722395:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.164279:0.736867:0.173092:0.736867:0.173092:0.722183:0.164279:0.722183:0.000000
 :@0.475814:0.737383:0.480028:0.737383:0.480028:0.722395:0.475814:0.722395:0.000000
:@0.097027:0.751671:0.105840:0.751671:0.105840:0.736986:0.097027:0.736986:0.000000
 Possible impaired sperm function   Iv solution :@0.105840:0.752187:0.480028:0.752187:0.480028:0.737198:0.105840:0.737198:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.379140:0.751671:0.387953:0.751671:0.387953:0.736986:0.379140:0.736986:0.000000
reacts with PvC; use glass bottles and keep dark:@0.097047:0.766990:0.462441:0.766990:0.462441:0.752001:0.097047:0.752001:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions::@0.097047:0.786252:0.252006:0.786252:0.252006:0.769861:0.097047:0.769861:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.251927:0.780444:0.258153:0.780444:0.258153:0.770888:0.251927:0.770888:0.000000
Cytochrome P450 3a4 inducers and inhibitors  :@0.096970:0.801030:0.479970:0.801030:0.479970:0.786041:0.096970:0.786041:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.815317:0.105783:0.815317:0.105783:0.800633:0.096970:0.800633:0.000000
 alcohol   Grapefruit juice:@0.105783:0.815833:0.303768:0.815833:0.303768:0.800844:0.105783:0.800844:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.172996:0.815317:0.181809:0.815317:0.181809:0.800633:0.172996:0.800633:0.000000
Verapamil:@0.096970:0.844183:0.207524:0.844183:0.207524:0.822628:0.096970:0.822628:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
verapamil is a non-dihydropyridine CCb. :@0.096970:0.857881:0.407773:0.857881:0.407773:0.842893:0.096970:0.842893:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Indications::@0.096970:0.877143:0.197357:0.877143:0.197357:0.860752:0.096970:0.860752:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.197355:0.871359:0.203581:0.871359:0.203581:0.861803:0.197355:0.861803:0.000000
angina pectoris   Mild to moderate hypertension :@0.096970:0.891944:0.479970:0.891944:0.479970:0.876955:0.096970:0.876955:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.222411:0.891428:0.231224:0.891428:0.231224:0.876744:0.222411:0.876744:0.000000
:@0.096970:0.906232:0.105783:0.906232:0.105783:0.891547:0.096970:0.891547:0.000000
 Supraventricular  tachydysrhythmia :@0.105783:0.906747:0.406291:0.906747:0.406291:0.891759:0.105783:0.891759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.419030:0.906232:0.427843:0.906232:0.427843:0.891547:0.419030:0.891547:0.000000
 Pro-:@0.427843:0.906747:0.475776:0.906747:0.475776:0.891759:0.427843:0.891759:0.000000:0.000000:0.000000:0.000000:0.000000
phylaxis of supraventricular relapse after electro-:@0.096989:0.921551:0.475795:0.921551:0.475795:0.906562:0.096989:0.906562:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
cardioversion:@0.096989:0.936645:0.199724:0.936645:0.199724:0.921657:0.096989:0.921657:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage:  :@0.524266:0.096567:0.603781:0.096562:0.603781:0.080172:0.524266:0.080176:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.593668:0.090778:0.599894:0.090778:0.599894:0.081222:0.593668:0.081222:0.000000
40-120 mg three times daily :@0.524233:0.111922:0.742615:0.111922:0.742615:0.096933:0.524233:0.096933:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.524233:0.131593:0.682021:0.131593:0.682021:0.115202:0.524233:0.115202:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.682027:0.125799:0.688254:0.125799:0.688254:0.116244:0.682027:0.116244:0.000000
retarded av conduction   acute stage of MI   Sick :@0.524242:0.146791:0.907223:0.146791:0.907223:0.131802:0.524242:0.131802:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.713587:0.146275:0.722400:0.146275:0.722400:0.131591:0.713587:0.131591:0.000000
:@0.861003:0.146275:0.869816:0.146275:0.869816:0.131591:0.861003:0.131591:0.000000
sinus syndrome    uncompensated heart failure :@0.524223:0.161991:0.907223:0.161991:0.907223:0.147002:0.524223:0.147002:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.655437:0.161475:0.664250:0.161475:0.664250:0.146791:0.655437:0.146791:0.000000
 :@0.903009:0.161991:0.907223:0.161991:0.907223:0.147002:0.903009:0.147002:0.000000
:@0.524223:0.176676:0.533036:0.176676:0.533036:0.161991:0.524223:0.161991:0.000000
 Hypotension associated with cardiogenic shock :@0.533036:0.177191:0.907204:0.177191:0.907204:0.162203:0.533036:0.162203:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524223:0.191876:0.533036:0.191876:0.533036:0.177191:0.524223:0.177191:0.000000
 Marked bradycardia   Pregnancy   breastfeeding:@0.533036:0.192392:0.903029:0.192392:0.903029:0.177403:0.533036:0.177403:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.689957:0.191876:0.698770:0.191876:0.698770:0.177191:0.689957:0.177191:0.000000
:@0.786073:0.191876:0.794886:0.191876:0.794886:0.177191:0.786073:0.177191:0.000000
Side effects::@0.524242:0.212064:0.627458:0.212064:0.627458:0.195673:0.524242:0.195673:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.627457:0.206294:0.633683:0.206294:0.633683:0.196739:0.627457:0.196739:0.000000
GI disturbances :@0.524242:0.227286:0.665423:0.227286:0.665423:0.212297:0.524242:0.212297:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.683684:0.226770:0.692497:0.226770:0.692497:0.212086:0.683684:0.212086:0.000000
 Headache :@0.692497:0.227286:0.796810:0.227286:0.796810:0.212297:0.692497:0.212297:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.815072:0.226770:0.823885:0.226770:0.823885:0.212086:0.815072:0.212086:0.000000
 Fatigue :@0.823885:0.227286:0.907243:0.227286:0.907243:0.212297:0.823885:0.212297:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903029:0.227286:0.907243:0.227286:0.907243:0.212297:0.903029:0.212297:0.000000
:@0.524242:0.241970:0.533055:0.241970:0.533055:0.227286:0.524242:0.227286:0.000000
 Palpitations   av and Sa blockade   dizziness :@0.533055:0.242486:0.907262:0.242486:0.907262:0.227498:0.533055:0.227498:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.635213:0.241970:0.644026:0.241970:0.644026:0.227286:0.635213:0.227286:0.000000
:@0.817612:0.241970:0.826425:0.241970:0.826425:0.227286:0.817612:0.227286:0.000000
:@0.524261:0.257171:0.533074:0.257171:0.533074:0.242486:0.524261:0.242486:0.000000
 urticaria   Skin rash   Increase of transaminase :@0.533074:0.257687:0.907243:0.257687:0.907243:0.242698:0.533074:0.242698:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.608158:0.257171:0.616971:0.257171:0.616971:0.242486:0.608158:0.242486:0.000000
:@0.697212:0.257171:0.706025:0.257171:0.706025:0.242486:0.697212:0.242486:0.000000
and/or alkaline phosphatise and bilirubin :@0.524261:0.272887:0.907262:0.272887:0.907262:0.257898:0.524261:0.257898:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903048:0.272887:0.907262:0.272887:0.907262:0.257898:0.903048:0.257898:0.000000
:@0.524261:0.287571:0.533074:0.287571:0.533074:0.272887:0.524261:0.272887:0.000000
 Symptomatic hypotension in normotensive :@0.533074:0.288087:0.907300:0.288087:0.907300:0.273098:0.533074:0.273098:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
patients    exacerbation of arthritis   Increased :@0.524261:0.303287:0.907262:0.303287:0.907262:0.288299:0.524261:0.288299:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.595073:0.302772:0.603886:0.302772:0.603886:0.288087:0.595073:0.288087:0.000000
:@0.811762:0.302772:0.820575:0.302772:0.820575:0.288087:0.811762:0.288087:0.000000
urination   Gum burn   Mild tremor   Severe facial :@0.524261:0.318488:0.907262:0.318488:0.907262:0.303499:0.524261:0.303499:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.597344:0.317972:0.606157:0.317972:0.606157:0.303287:0.597344:0.303287:0.000000
:@0.691497:0.317972:0.700310:0.317972:0.700310:0.303287:0.691497:0.303287:0.000000
:@0.796964:0.317972:0.805777:0.317972:0.805777:0.303287:0.796964:0.303287:0.000000
pain:@0.524261:0.333688:0.557954:0.333688:0.557954:0.318699:0.524261:0.318699:0.000000:0.000000:0.000000:0.000000
Special precautions::@0.524261:0.353360:0.696692:0.353360:0.696692:0.336969:0.524261:0.336969:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.696670:0.347617:0.702896:0.347617:0.702896:0.338061:0.696670:0.338061:0.000000
Control  mild  ventricular  dysfunction  first  with :@0.524242:0.368608:0.907204:0.368608:0.907204:0.353620:0.524242:0.353620:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
digitalis and/or diuretics   Possible digitalis :@0.524242:0.383809:0.907262:0.383809:0.907262:0.368820:0.524242:0.368820:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.744375:0.383293:0.753188:0.383293:0.753188:0.368608:0.744375:0.368608:0.000000
toxicity   Impaired hepatic or renal function  :@0.524242:0.399009:0.907243:0.399009:0.907243:0.384020:0.524242:0.384020:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.591244:0.398493:0.600057:0.398493:0.600057:0.383809:0.591244:0.383809:0.000000
:@0.524242:0.413693:0.533055:0.413693:0.533055:0.399009:0.524242:0.399009:0.000000
 atrial fibrillation   Hypertrophic cardiomyopathy :@0.533055:0.414209:0.907281:0.414209:0.907281:0.399221:0.533055:0.399221:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.659939:0.413693:0.668752:0.413693:0.668752:0.399009:0.659939:0.399009:0.000000
:@0.524261:0.428894:0.533074:0.428894:0.533074:0.414209:0.524261:0.414209:0.000000
 attenuate neuromuscular transmission   do not :@0.533074:0.429410:0.907281:0.429410:0.907281:0.414421:0.533074:0.414421:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.837450:0.428894:0.846263:0.428894:0.846263:0.414209:0.837450:0.414209:0.000000
administer disopyramide within 48 hours prior to :@0.524280:0.444610:0.907281:0.444610:0.907281:0.429621:0.524280:0.429621:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
or 24 hours after verapamil   avoid concomitant :@0.524280:0.459810:0.907281:0.459810:0.907281:0.444822:0.524280:0.444822:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.740334:0.459294:0.749147:0.459294:0.749147:0.444610:0.740334:0.444610:0.000000
quinidine in hypertrophic cardiomyopathy :@0.524280:0.475011:0.907281:0.475011:0.907281:0.460022:0.524280:0.460022:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903067:0.475011:0.907281:0.475011:0.907281:0.460022:0.903067:0.460022:0.000000
:@0.524280:0.489695:0.533093:0.489695:0.533093:0.475011:0.524280:0.475011:0.000000
 Inhalation anaesthesia:@0.533093:0.490211:0.708392:0.490211:0.708392:0.475222:0.533093:0.475222:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions::@0.524280:0.509883:0.679239:0.509883:0.679239:0.493492:0.524280:0.493492:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.679199:0.504147:0.685425:0.504147:0.685425:0.494591:0.679199:0.494591:0.000000
b-receptor blockers    other antihypertensives :@0.524242:0.525138:0.907243:0.525138:0.907243:0.510149:0.524242:0.510149:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.691497:0.524622:0.700310:0.524622:0.700310:0.509938:0.691497:0.509938:0.000000
:@0.524242:0.539822:0.533055:0.539822:0.533055:0.525138:0.524242:0.525138:0.000000
 Flecainide :@0.533055:0.540338:0.630460:0.540338:0.630460:0.525350:0.533055:0.525350:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.642005:0.539822:0.650818:0.539822:0.650818:0.525138:0.642005:0.525138:0.000000
 Quinidine :@0.650799:0.540338:0.746395:0.540338:0.746395:0.525350:0.650799:0.525350:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.757941:0.539822:0.766754:0.539822:0.766754:0.525138:0.757941:0.525138:0.000000
 Carbamazepine :@0.766735:0.540338:0.907243:0.540338:0.907243:0.525350:0.766735:0.525350:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903029:0.540338:0.907243:0.540338:0.907243:0.525350:0.903029:0.525350:0.000000
:@0.524242:0.555023:0.533055:0.555023:0.533055:0.540338:0.524242:0.540338:0.000000
  rifampicin    Phenobarbital    Cyclosporine :@0.533055:0.555539:0.907262:0.555539:0.907262:0.540550:0.533055:0.540550:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.639523:0.555023:0.648336:0.555023:0.648336:0.540338:0.639523:0.540338:0.000000
:@0.782052:0.555023:0.790865:0.555023:0.790865:0.540338:0.782052:0.540338:0.000000
 :@0.903048:0.555539:0.907262:0.555539:0.907262:0.540550:0.903048:0.540550:0.000000
:@0.524261:0.570223:0.533074:0.570223:0.533074:0.555539:0.524261:0.555539:0.000000
 Simvastatin   lovastatin   Grapefruit juice:@0.533074:0.570739:0.855596:0.570739:0.855596:0.555750:0.533074:0.555750:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.629594:0.570223:0.638407:0.570223:0.638407:0.555539:0.629594:0.555539:0.000000
:@0.724825:0.570223:0.733638:0.570223:0.733638:0.555539:0.724825:0.555539:0.000000
Blockers of the renin-angiotensin-:@0.524242:0.599223:0.899341:0.599223:0.899341:0.577668:0.524242:0.577668:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
aldosterone system :@0.524242:0.618255:0.745709:0.618255:0.745709:0.596700:0.524242:0.596700:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
overreaction of the renin-angiotensin-aldos-:@0.524242:0.632356:0.903029:0.632356:0.903029:0.617367:0.524242:0.617367:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
terone system (raaS) plays a major role in the :@0.524242:0.647556:0.907224:0.647556:0.907224:0.632568:0.524242:0.632568:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
pathogenesis of hypertension and blockage :@0.524242:0.662757:0.907224:0.662757:0.907224:0.647768:0.524242:0.647768:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
thereof is a therapeutic target in patients with :@0.524242:0.677957:0.907243:0.677957:0.907243:0.662968:0.524242:0.662968:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hypertension. raaS is involved in controlling the :@0.524242:0.693157:0.907262:0.693157:0.907262:0.678169:0.524242:0.678169:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
circulating volume and electrolyte balance and :@0.524242:0.708358:0.907243:0.708358:0.907243:0.693369:0.524242:0.693369:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
in hypertension this entails retaining  na  and :@0.524242:0.723558:0.907238:0.723597:0.907238:0.708609:0.524242:0.708569:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
+:@0.856891:0.717813:0.863577:0.717813:0.863577:0.709074:0.856891:0.709074:0.000000
water.:@0.524237:0.738798:0.570188:0.738798:0.570188:0.723809:0.524237:0.723809:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
19,20 :@0.570192:0.733020:0.596499:0.733020:0.596499:0.724281:0.570192:0.724281:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.596498:0.738804:0.600712:0.738804:0.600712:0.723816:0.596498:0.723816:0.000000
a key enzyme involved in the  raaS is :@0.542427:0.754005:0.907263:0.754005:0.907263:0.739016:0.542427:0.739016:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
angiotensin-converting enzyme (aCe).  this :@0.524243:0.769205:0.907244:0.769205:0.907244:0.754216:0.524243:0.754216:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
enzyme is responsible for the conversion :@0.524243:0.784405:0.907244:0.784405:0.907244:0.769417:0.524243:0.769417:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of inactive angiotensin I into the potent :@0.524243:0.799605:0.907205:0.799605:0.907205:0.784617:0.524243:0.784617:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
vasoconstrictor angiotensin II.  angiotensin II :@0.524243:0.814806:0.907225:0.814806:0.907225:0.799817:0.524243:0.799817:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
increases blood pressure and stimulates the :@0.524243:0.830006:0.907263:0.830006:0.907263:0.815017:0.524243:0.815017:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
production of aldosterone.  Inhibition of aCe not :@0.524243:0.845206:0.907244:0.845206:0.907244:0.830218:0.524243:0.830218:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
only prevents the conversion of angiotensin I into :@0.524243:0.860407:0.907282:0.860407:0.907282:0.845418:0.524243:0.845418:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
its active form, but also prevents the formation :@0.524243:0.875607:0.907205:0.875607:0.907205:0.860618:0.524243:0.860618:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of aldosterone and decreases the degradation of :@0.524243:0.890807:0.907282:0.890807:0.907282:0.875819:0.524243:0.875819:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
bradykinin.  bradykinin releases nitric oxide and :@0.524243:0.906008:0.907225:0.906008:0.907225:0.891019:0.524243:0.891019:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
prostaglandins, increasing the vasodilatory effects :@0.524243:0.921208:0.907263:0.921208:0.907263:0.906219:0.524243:0.906219:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of aCeIs.:@0.524243:0.936567:0.589128:0.936567:0.589128:0.921578:0.524243:0.921578:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
7,19,20 :@0.589127:0.930856:0.622860:0.930856:0.622860:0.922118:0.589127:0.922118:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.622859:0.936641:0.627073:0.936641:0.627073:0.921652:0.622859:0.921652:0.000000